These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24054775)

  • 1. [Ipilimumab-induced poliosis].
    Victoria Martínez AM; Estela Cubells JR; Cubells Sánchez L; Oliver Martínez V; Alegre de Miguel V
    Med Clin (Barc); 2014 Mar; 142(5):234. PubMed ID: 24054775
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible hair depigmentation in a patient treated with imatinib.
    Mariani S; Abruzzese E; Basciani S; Fiore D; Persichetti A; Watanabe M; Spera G; Gnessi L
    Leuk Res; 2011 Jun; 35(6):e64-6. PubMed ID: 21176848
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertrichosis of the malar areas and poliosis of the eyelashes caused by latanoprost.
    Özyurt S; Çetinkaya GS
    Actas Dermosifiliogr; 2015; 106(1):74-5. PubMed ID: 25065768
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trichomegaly due to cetuximab].
    Bagazgoitia L; Aboín S; Beà S; Muñoz E
    Med Clin (Barc); 2009 Sep; 133(8):323. PubMed ID: 19540538
    [No Abstract]   [Full Text] [Related]  

  • 5. Trichomegaly of the eyelashes following treatment with cetuximab.
    Vaccaro M; Pollicino A; Barbuzza O; Guarneri B
    Clin Exp Dermatol; 2009 Apr; 34(3):402-3. PubMed ID: 19120397
    [No Abstract]   [Full Text] [Related]  

  • 6. Alopecia areata with white hair regrowth: case report and review of poliosis.
    Jalalat SZ; Kelsoe JR; Cohen PR
    Dermatol Online J; 2014 Sep; 20(9):. PubMed ID: 25244170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichomegaly of the eyelashes following treatment with cetuximab.
    Bouché O; Brixi-Benmansour H; Bertin A; Perceau G; Lagarde S
    Ann Oncol; 2005 Oct; 16(10):1711-2. PubMed ID: 15972283
    [No Abstract]   [Full Text] [Related]  

  • 8. [Depigmentation of the skin and hair after phenobarbital induced eruption].
    Mion N; Fusade T; Mathelier-Fusade P; Joly P; Belanyi P; Balguerie X; Chosidow O; Thomine E; Lauret P
    Ann Dermatol Venereol; 1992; 119(11):927-9. PubMed ID: 1301725
    [No Abstract]   [Full Text] [Related]  

  • 9. Hair discoloration caused by etretinate.
    Nanda A; Alsaleh QA
    Dermatology; 1994; 188(2):172. PubMed ID: 8136552
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitiligo-like hypopigmentation with poliosis following treatment of superficial basal cell carcinoma with imiquimod.
    Jacob SE; Blyumin M
    Dermatol Surg; 2008 Jun; 34(6):844-5. PubMed ID: 18363730
    [No Abstract]   [Full Text] [Related]  

  • 11. [EGFR (epidermal growth factor receptor) inhibitor-associated skin disorders in tumor therapy].
    Reimer G; Brudler O; Heinrich B; Bangerter M
    MMW Fortschr Med; 2008 Dec; 150(49-50):37-8, 40. PubMed ID: 19133368
    [No Abstract]   [Full Text] [Related]  

  • 12. Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases.
    Fabbrocini G; Panariello L; Cacciapuoti S; Bianca D; Ayala F
    Dermatitis; 2012; 23(5):237-8. PubMed ID: 23010833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair depigmentation and vitiligo-like lesions in a leukaemic paediatric patient during chemotherapy with dasatinib.
    Brazzelli V; Grasso V; Barbaccia V; Manna G; Rivetti N; Zecca M; Giorgiani G; Vassallo C; Borroni G
    Acta Derm Venereol; 2012 Mar; 92(2):218-9. PubMed ID: 22307953
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alopecia and hair changes following colchicine therapy].
    Harms M
    Hautarzt; 1980 Mar; 31(3):161-3. PubMed ID: 7399906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poliosis circumscripta: overview and underlying causes.
    Sleiman R; Kurban M; Succaria F; Abbas O
    J Am Acad Dermatol; 2013 Oct; 69(4):625-33. PubMed ID: 23850259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and pathophysiology of EGFRI dermatologic toxicities.
    Mitchell EP; Perez-Soler R; Van Cutsem E; Lacouture ME
    Oncology (Williston Park); 2007 Oct; 21(11 Suppl 5):4-9. PubMed ID: 18154212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hair graying and loss induced by imatinib mesylate.
    Yun SK; Song KH; Hwang SR; Kim HU; Lee NR; Park J
    J Dermatol; 2014 Jan; 41(1):107-8. PubMed ID: 24354806
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monoclonal antibodies and chemotherapy: planning and management of symptoms].
    Berardini R
    Suppl Tumori; 2004; 3(4):S130-2. PubMed ID: 15206239
    [No Abstract]   [Full Text] [Related]  

  • 19. Loose anagen hair syndrome: an unusual cause of alopecia of cosmetic importance only.
    Santiago F; Vieira R; Figueiredo A
    J Cosmet Dermatol; 2009 Sep; 8(3):226-7. PubMed ID: 19735522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Panitumumab-induced trichomegaly].
    Vañó-Galván S; Longo F; Grillo E; Jaén P
    Med Clin (Barc); 2013 Apr; 140(8):e15. PubMed ID: 23490492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.